Clearside Biomedical Announces Approval of XIPERE® Suprachoroida... ... SAN ANTONIO --(BUSINESS WIRE)-- XPEL, Inc. (Nasdaq: XPEL) a global ...
News
- XPEL, Inc. to Host Conference Call to Discuss Second Quarter 2025 Results - Stock Titan
- Newleos Therapeutics Appoints Stephen Brannan to Board of Directors and Announces ...
BOSTON--(BUSINESS WIRE)--#AnxietyDisorders--Newleos Therapeutics, Inc., a clinical-stage biotechnology ... San Antonio (UTHSCSA), specializing in mood ...
- Owner of L.A. Times taking paper public - PressReader
San Antonio Express-News. Owner of L.A. Times taking paper public. 2025 ... Soon-shiong, a biotech billionaire, acquired the Times as part of a ...
- Q2 2025 Earnings Call: Usio to Present Latest Financial Results - Stock Titan
Clearside Biomedical Announces Approval of XIPERE® Suprachoroida... ... SAN ANTONIO, July 23, 2025 (GLOBE NEWSWIRE) -- Usio, Inc. (Nasdaq:USIO) ...
- Coriolis Pharma to Invest $10 Million in New Morrisville Lab, Creating - Hoodline
... biotech innovation in the region ... SAN ANTONIO SAN DIEGO SEATTLE TAMPA WASHINGTON, D.C.. © 2025 SFist LLC ...